Michael Girardi (M Girardi)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 14

Top Topics

Regulatory T Cells

Top Venues

Nature communications

Proceedings of the National Academy of Sciences of the United States of America

The British journal of dermatology

This page only lists publications with an associated author ORCID identifier.

Publications

Jingjing Ren, Xiaofeng Liao, Julia M Lewis, Jungsoo Chang, Rihao Qu, Kacie R Carlson, Francine M Foss, Michael Girardi
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy. Nature communications 15 (1) (2024)
Jingjing Ren, Xiaofeng Liao, Julia M Lewis, Jungsoo Chang, Rihao Qu, Kacie R Carlson, Francine M Foss, Michael Girardi
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy. Nature communications 15 (1) (2024)
Michael Girardi, Kacie Carlson, Xingyue Huang, Shelby L Corman, Patrick Edmundson, Jordana K Schmier, Hrishikesh P Kale, Rutika Raina, Francine Foss
Chart review study of real-world clinical outcomes in patients with cutaneous T-cell lymphoma treated with extracorporeal photopheresis in the US in 2017-2019. The Journal of dermatological treatment 35 (1) (2024)
Madisen A Swallow, Goran Micevic, Amanda G Zhou, Kacie R Carlson, Francine M Foss, Michael Girardi
Clinical and Histologic Variants of CD8+ Cutaneous T-Cell Lymphomas. Cancers 16 (17) (2024)
Jingjing Ren, Xiaofeng Liao, Julia M Lewis, Jungsoo Chang, Rihao Qu, Kacie R Carlson, Francine M Foss, Michael Girardi
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy. Nature communications 15 (1) (2024)
Jingjing Ren, Xiaofeng Liao, Julia M Lewis, Jungsoo Chang, Rihao Qu, Kacie R Carlson, Francine M Foss, Michael Girardi
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy. Nature communications 15 (1) (2024)
Jingjing Ren, Xiaofeng Liao, Julia M Lewis, Jungsoo Chang, Rihao Qu, Kacie R Carlson, Francine M Foss, Michael Girardi
Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy. Nature communications 15 (1) (2024)
Jingjing Ren, Rihao Qu, Nur-Taz Rahman, Julia M Lewis, Amber Loren Ong King, Xiaofeng Liao, Fatima N Mirza, Kacie R Carlson, Yaqing Huang, Scott Gigante, Benjamin R Evans, Barani Kumar Rajendran, Suzanne Xu, Guilin Wang, Francine M Foss, William Damsky, Yuval Kluger, Smita Krishnaswamy, Michael Girardi
Integrated transcriptome and trajectory analysis of cutaneous T-cell lymphoma identifies putative precancer populations. Blood advances (2022)
Shayan Cheraghlou, Praneeth Sadda, George O Agogo, Michael Girardi
A machine-learning modified CART algorithm informs Merkel cell carcinoma prognosis. The Australasian journal of dermatology 62 (3) (2021)
Jamie K Hu, Hee Won Suh, Munibah Qureshi, Julia M Lewis, Sharon Yaqoob, Zoe M Moscato, Sofia Griff, Alison K Lee, Emily S Yin, W Mark Saltzman, Michael Girardi
Nonsurgical treatment of skin cancer with local delivery of bioadhesive nanoparticles. Proceedings of the National Academy of Sciences of the United States of America 118 (7) (2021)
Julia M Lewis, Patrick F Monico, Fatima N Mirza, Suzanne Xu, Sara Yumeen, Jack L Turban, Anjela Galan, Michael Girardi
Chronic UV radiation-induced RORγt+ IL-22-producing lymphoid cells are associated with mutant KC clonal expansion. Proceedings of the National Academy of Sciences of the United States of America 118 (37) (2021)
Fatima N Mirza, Sara Yumeen, Michael Girardi
Disparities in outcomes of CD8+ cutaneous T-cell lymphoma by race and presenting lesion location. The British journal of dermatology 184 (1) (2020)
Shayan Cheraghlou, G O Agogo, Michael Girardi
Improving prognosis for early-stage Merkel cell carcinoma: trends from 1981 to 2014. The British journal of dermatology 182 (3) (2019)
Benoit M Cyrenne, Julia M Lewis, Jason G Weed, Kacie R Carlson, Fatima N Mirza, Francine M Foss, Michael Girardi
Synergy of BCL2 and histone deacetylase inhibition against leukemic cells from cutaneous T-cell lymphoma patients. Blood 130 (19) (2017)